- Exchange: Toronto
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
Snapshot for QLT Inc (QLT)
| Open: | 7.8200 | Day's Range: | 7.6300 - 7.8600 | Volume: | 18,492 | Bid: | 7.7300 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 7.9200 | 52wk Range: | 5.3400 - 8.0000 | 1-Yr Rtn: | +6.76% | Ask: | 7.7900 |
Key Statistics for QLT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -0.7700 |
| Est. EPS (USD) (12/2012) | -1.0070 |
| Est. PEG Ratio | - |
| Market Cap (M CAD) | 379.81 |
| Shares Outstanding (M) | 49.07 |
| Enterprise Value (M USD) (ttm) | 163.17 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 1.1571 |
| Price/Sale (ttm) | 8.8542 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 07/27/2012 |
More QLT Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for QLT
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for QLT
QLT Inc. develops and commercializes pharmaceutical products for use in photodynamic therapy, the use of light activated drugs to treat disease. The Company's lead drug, Visudyne, is marketed by Novartis AG, and is used in the treatment of the wet form of age-related macular degeneration.
| C Boyd ClarkeChairman | Robert L Butchofsky "Bob"President/CEO |
| Linda M LupiniSenior VP:Human Resources | Alexander R LussowSenior VP:Business Development |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page